1 January 2016 in Journal of Pharmaceutical and Biomedical Analysis
19 November 2009 in Journal of Chromatography B
6 November 2018 in Pharmaceutical Technology in Hospital Pharmacy
Background Water-soluble vitamins are often included simultaneously in pharmaceutical formulations as food complements or in parenteral nutrition mixtures. Given their sensitivity to heat, light or pH variations, it is important to study their stability using validated stability indicating methods. We thus aimed to validate a liquid chromatography (LC) stability-indicating method for the simultaneous quantification of 5 water-soluble vitamins. Methods We analyzed four water-soluble B vitamins (nicotinamide, pyridoxine, folic acid, cyanocobalamin) and ascorbic acid using a LC method with diode array detector. They were separated on a C18 stationary phase under gradient elution of solvent A [0.2 % of metaphosphoric acid in water and acetonitrile 98:2] and solvent B (100 % acetonitrile). All vitamins were subjected to forced degradation conditions and we showed that the obtained degradation products didn’t interfere with the vitamins. Results The method allows the separation of the 5 water-soluble vitamins in a 30 minute run without any interference from the breakdown products obtained with acid/alkaline solutions, hydrogen peroxide, temperature and light. It meets all the qualitative and quantitative criteria for validation with an acceptable accuracy and good linearity. Conclusions This stability-indicating method can be used for carrying out stability studies of water-soluble vitamins in pharmaceutical preparations.
16 October 2012 in European Journal of Hospital Pharmacy
Study objective The intracameral injection of cefuroxime has shown its effectiveness in the prevention of endophthalmitis consecutive to cataract surgery. The solution is generally loaded into syringes that are deep frozen to ensure stability before use. However, a concentration gradient has been found inside the syringes after thawing. We set out to determine the optimal thawing conditions that would ensure homogeneity. Method Solutions of cefuroxime in pre-filled syringes were deep frozen at −20°C and thawed at 15, 20 and 25°C with or without homogenisation. Samples were taken from three segments of each syringe immediately after preparation and then 15, 30 and 60 min after removal from the freezer. Cefuroxime was assayed by high-performance liquid chromatography and temperature in the solution was monitored using a thermocouple. Measurement of pH, osmolality and particulate matter were also performed. Results Before thawing, the cefuroxime concentration is homogeneous in the syringes. After 15 min of thawing at 15, 20 and 25°C without homogenisation, a steep concentration gradient is observed, with a variation in cefuroxime concentration of ±25–30% along the syringe. After 1 h of thawing, the concentration variations are narrower, about 15%. Manual homogenisation of the solutions gives a stable concentration after 15 min of thawing between 15 and 25°C, but the solution takes fully 30 min to reach the ambient temperature. The solution of cefuroxime displays a pH, an osmolality and a particle count that were compatible with intracameral injection. Conclusions This study demonstrates the need to let syringes containing cefuroxime thaw out for 30 min between 15 and 25°C and to homogenise the contents at least by inversion of the syringe before injecting into the patient. If this procedure is not followed, the patient may be exposed to overdosing or underdosing of cefuroxime according to whether the surgeon injects the first or the last 0.1 ml of the solution.